U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07314073) titled '[18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer' on Dec. 03, 2025.
Brief Summary: This study aims to evaluate the detection rate of distant metastases using [18F]FES PET/CT in patients with low-grade, ER-positive stage III breast cancer.
Study Start Date: Dec. 24, 2025
Study Type: INTERVENTIONAL
Condition:
Stage III Breast Cancer
Intervention:
DIAGNOSTIC_TEST: Fluoroestradiol (18F)
Images for 90 minutes after F-18 FES injection
Recruitment Status: RECRUITING
Sponsor: Asan Medical Center
Information provided by (Responsible Party): Hyehyun Jeong, Asan Medical Center
D...